About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
Press ReleaseCardiawave annonce la publication dans The Lancet des résultats de ses études cliniques « First-in-Human » Nov 14, 2023 READ MORE
Scientific PublicationsFocused Ultrasound Foundation’s article regarding the safety of Cardiawave’s Focused Ultrasound Treatment of Aortic Valve Stenosis! Jul 24, 2023 READ MORE
Clinical StudiesPatient Inclusion Completed for Cardiawave’s “Valvosoft® Pivotal Study”! Jul 17, 2023 READ MORE
EventsBest oral presentation award for Clara Magnier, our CIFRE PhD student – July 5 – Paris Jul 5, 2023 © CNRS READ MORE
About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
